البحث عن طبيب

Neera K. Dahl, M.D., Ph.D.

  1. Internist
  2. Nephrologist

المنشورات

  1. Chebib FT, Nowak KL, Chonchol MB, Bing K, Ghanem A, Rahbari-Oskoui FF, Dahl NK, Mrug M. Polycystic Kidney Disease Diet: What is Known and What is Safe. Clin J Am Soc Nephrol. 2024 May 1; 19 (5):664-682 Epub 2023 Sept 20
    View PubMed
  2. Hoover E, Holliday V, Merullo N, Oberdhan D, Perrone RD, Rusconi C, Park M, Phadnis MA, Thewarapperuma N, Dahl NK. Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry. Kidney Med. 2024 May; 6 (5):100813 Epub 2024 Mar 24
    View PubMed
  3. Simmons KE, Ullman LS Jr, Dahl NK. Kidney Stones Account for Increased Imaging Studies in Autosomal Dominant Polycystic Kidney Disease. Kidney360 2024 May 1; 5 (5):707-714 Epub 2024 Mar 25
    View PubMed
  4. Thompson WS, Babayev SN, McGowan ML, Kattah AG, Wick MJ, Bendel-Stenzel EM, Chebib FT, Harris PC, Dahl NK, Torres VE, Hanna C. State of the Science and Ethical Considerations for Preimplantation Genetic Testing for Monogenic Cystic Kidney Diseases and Ciliopathies. J Am Soc Nephrol. 2024 Feb 1; 35 (2):235-248 Epub 2023 Oct 26
    View PubMed
  5. Aklilu AM, Gulati A, Kolber KJ, Yang H, Harris PC, Dahl NK. The VUS Challenge in Cystic Kidney Disease: A Case-Based Review. Kidney360. 2024 Jan 1; 5 (1):152-159 Epub 2023 Nov 14
    View PubMed
  6. EMPA-KIDNEY Collaborative Group. Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial. Lancet Diabetes Endocrinol. 2024 Jan; 12 (1):39-50 Epub 2023 Dec 04
    View PubMed
  7. EMPA-KIDNEY Collaborative Group. Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial. Lancet Diabetes Endocrinol. 2024 Jan; 12 (1):51-60 Epub 2023 Dec 04
    View PubMed
  8. Hogan MC, Simmons K, Ullman L Jr, Gondal M, Dahl NK. Beyond Loss of Kidney Function: Patient Care in Autosomal Dominant Polycystic Kidney Disease. Kidney360. 2023 Dec 1; 4 (12):1806-1815 Epub 2023 Nov 27
    View PubMed
  9. Dahl NK, Bloom MS, Chebib FT, Clark D, Westemeyer M, Jandeska S, Zhang Z, Milo-Rasouly H, Kolupaeva V, Marasa M, Broumand V, Fatica RA, Raj DS, Demko ZP, Marshall K, Punj S, Tabriziani H, Bhorade S, Gharavi AG. The Clinical Utility of Genetic Testing in the Diagnosis and Management of Adults with Chronic Kidney Disease. J Am Soc Nephrol. 2023 Dec 1; 34 (12):2039-2050 Epub 2023 Oct 05
    View PubMed
  10. Noce EM, Brereton L, Zorzanello M, Aklilu A, Anders E, Bernal M, Sundararajan A, Dahl NK, Kodali R, Patel DM. Dialysis Patient Experiences During the COVID-19 Pandemic: A Survey Study. Kidney Med. 2023 Jul; 5 (7):100673 Epub 2023 May 16
    View PubMed
  11. Kostiuk V, Chen JF, Dahl NK, Turner J, Ochoa Chaar CI. Hybrid Revision of Dysfunctional Aneurysmal Arteriovenous Fistulas. Vasc Endovascular Surg. 2023 Jun 10; 15385744231183488 Epub 2023 June 10
    View PubMed
  12. Simmons K, Nair H, Phadke M, Motamedinia P, Singh D, Montgomery T, Dahl NK. Risk Factors for Common Kidney Stones Are Correlated with Kidney Function Independent of Stone Composition. Am J Nephrol. 2023 May 30 [Epub ahead of print]
    View PubMed
  13. Ackley W, Dahl NK, Park M. Pharmacologic Management of Autosomal Dominant Polycystic Kidney Disease. Adv Kidney Dis Health. 2023 May; 30 (3):228-235
    View PubMed
  14. Patel DM, Page N, Dahl NK. Kidney cysts in patients with HOGA1 variants. Clin Nephrol. 2023 Mar 17 [Epub ahead of print]
    View PubMed
  15. Gulati A, Dahl NK, Hartung EA, Clark SL, Moudgil A, Goodwin J, Somlo S. Hypomorphic PKD1 Alleles Impact Disease Variability in Autosomal Dominant Polycystic Kidney Disease. Kidney360. 2023 Mar 1; 4 (3):387-392
    View PubMed
  16. Mekahli D, Womack H, Dahl NK. Perspectives on Drug Development in Early ADPKD. Clin J Am Soc Nephrol. 2022 Oct; 17 (10):1555-1558 Epub 2022 Aug 23
    View PubMed
  17. Aron AW, Dahl NK, Besse W. A Practical Guide to Genetic Testing for Kidney Disorders of Unknown Etiology. Kidney360. 2022 Sep 29; 3 (9):1640-1651 Epub 2022 July 08
    View PubMed
  18. Hoover E, Perrone RD, Rusconi C, Benson B, Dahl NK, Gitomer B, Manelli A, Mrug M, Park M, Seliger SL, Phadnis MA, Thewarapperuma N, Watnick TJ. Design and Basic Characteristics of a National Patient-Powered Registry in ADPKD. Kidney360. 2022 Aug 25; 3 (8):1350-1358 Epub 2022 May 20
    View PubMed
  19. Patel DM, Cantley L, Moeckel G, Dahl NK, Luciano R. IgA vasculitis complicated by acute kidney failure with thrombotic microangiopathy: successful use of eculizumab. J Nephrol. 2021 Dec; 34 (6):2141-2145 Epub 2021 May 21
    View PubMed
  20. Malhotra D, Dahl NK. An Unusual Cause of AKI in a Kidney Transplant Recipient. Kidney360. 2021 Nov 25; 2 (11):1869-1870
    View PubMed
  21. Sundararajan A, Dahl NK, Latich I. An Unusual Cause of Peritoneal Dialysis Catheter Dysfunction. Kidney360. 2021 Sep 30; 2 (9):1540-1541 Epub 2021 Sept 30
    View PubMed
  22. Patel DM, Phadke M, Dai F, Simonov M, Dahl NK, Kodali R. Association of AKI-D with Urinary Findings and Baseline eGFR in Hospitalized COVID-19 Patients. Kidney360. 2021 Aug 26; 2 (8):1215-1224 Epub 2021 May 20
    View PubMed
  23. Patel DM, Dahl NK. Examining the Role of Novel CKD Therapies for the ADPKD Patient. Kidney360. 2021 Jun 24; 2 (6):1036-1041 Epub 2021 Mar 24
    View PubMed
  24. Rosenberg S, Virmani S, Klarman S, Santovasi S, Dai F, Dahl NK. Mayo Imaging Classification May Be Useful in Determining the Need for Nephrectomy in ADPKD. Kidney360. 2021 Feb 25; 2 (2):325-330 Epub 2020 Dec 30
    View PubMed
  25. Patel DM, Dahl NK. Long-Term Safety of Tolvaptan in ADPKD: Where Do We Stand? Clin J Am Soc Nephrol 2020 Dec 31; 16 (1):3-5 Epub 2020 Dec 29
    View PubMed
  26. Lee SR, Zhuo H, Zhang Y, Dahl N, Dardik A, Ochoa Chaar CI. Risk factors and safe contrast volume thresholds for postcontrast acute kidney injury after peripheral vascular interventions. J Vasc Surg. 2020 Aug; 72 (2):603-610.e1 Epub 2019 Dec 13
    View PubMed
  27. Turner AD, Chen M, Dahl N, Scoutt L, Dardik A, Ochoa Chaar CI. Intraoperative Ultrasound Guidance for Banding of an Arteriovenous Fistula Causing High Cardiac Output Heart Failure. Ann Vasc Surg. 2020 Jul; 66:665.e5-665.e8. Epub 2019 Dec 18.
    View PubMed
  28. Gulati A, Dahl N, Tufro A. Inherited glomerular diseases in the gilded age of genomic advancements. Pediatr Nephrol. 2020 Jun; 35 (6):959-968 Epub 2019 May 03
    View PubMed
  29. Marin EP, Cohen E, Dahl N. Clinical Applications of Genetic Discoveries in Kidney Transplantation: a Review. Kidney360. 2020 Apr 30; 1 (4):300-305 Epub 2020 Mar 11
    View PubMed
  30. Fereydooni MS, Dahl NK, Chaar CIO. Technical and Ethical Challenges in the Care of an Independent Nonagenarian with Critical Limb Ischemia Arch Clin Med Case Rep. 2020; 4(1):130-137.
  31. Gulati A, Sevillano AM, Praga M, Gutierrez E, Alba I, Dahl NK, Besse W, Choi J, Somlo S. Collagen IV Gene Mutations in Adults With Bilateral Renal Cysts and CKD. Kidney Int Rep. 2020 Jan; 5 (1):103-108 Epub 2019 Sept 11
    View PubMed
  32. Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D, SONAR Committees and Investigators. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Lancet. 2019 May 11; 393 (10184):1937-1947 Epub 2019 Apr 14
    View PubMed
  33. Murphy EL, Dai F, Blount KL, Droher ML, Liberti L, Crews DC, Dahl NK. Revisiting racial differences in ESRD due to ADPKD in the United States. BMC Nephrol. 2019 Feb 14; 20 (1):55
    View PubMed
  34. Brownstein AJ, Bin Mahmood SU, Saeyeldin A, Velasquez Mejia C, Zafar MA, Li Y, Rizzo JA, Dahl NK, Erben Y, Ziganshin BA, Elefteriades JA. Simple renal cysts and bovine aortic arch: markers for aortic disease. Open Heart. 2019; 6(1):e000862. Epub 2019 Jan 28.
    View PubMed
  35. Murphy EL, Droher ML, DiMaio MS, Dahl NK. Preimplantation Genetic Diagnosis Counseling in Autosomal Dominant Polycystic Kidney Disease. Am J Kidney Dis. 2018 Dec; 72 (6):866-872 Epub 2018 Mar 30
    View PubMed
  36. Gulati A, Bale AE, Dykas DJ, Bia MJ, Danovitch GM, Moeckel GW, Somlo S, Dahl NK. TREX1 Mutation Causing Autosomal Dominant Thrombotic Microangiopathy and CKD-A Novel Presentation. Am J Kidney Dis. 2018 Dec; 72 (6):895-899 Epub 2018 June 22
    View PubMed
  37. Chebib FT, Perrone RD, Chapman AB, Dahl NK, Harris PC, Mrug M, Mustafa RA, Rastogi A, Watnick T, Yu ASL, Torres VE. A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan. J Am Soc Nephrol. 2018 Oct; 29(10):2458-2470. Epub 2018 Sep 18.
    View PubMed
  38. Rauniyar N, Yu X, Cantley J, Voss EZ, Belcher J, Colangelo CM, Stone KL, Dahl N, Parikh C, Lam TT, Cantley LG. Quantification of Urinary Protein Biomarkers of Autosomal Dominant Polycystic Kidney Disease by Parallel Reaction Monitoring. Proteomics Clin Appl. 2018 Sep; 12 (5):e1700157 Epub 2018 May 02
    View PubMed
  39. Lee Y, Blount KL, Dai F, Thompson S, Scher JK, Bitterman S, Droher M, Herzog EL, Moeckel G, Karihaloo A, Dahl NK. Semaphorin 7A in circulating regulatory T cells is increased in autosomal-dominant polycystic kidney disease and decreases with tolvaptan treatment. Clin Exp Nephrol. 2018 Aug; 22 (4):906-916 Epub 2018 Feb 16
    View PubMed
  40. Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G, Ouyang J, McQuade RD, Blais JD, Czerwiec FS, Sergeyeva O, REPRISE Trial Investigators. Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease. N Engl J Med. 2017 Nov 16; 377 (20):1930-1942 Epub 2017 Nov 04
    View PubMed
  41. Vichot AA, Zsengeller ZK, Shmukler BE, Adams ND, Dahl NK, Alper SL. Loss of kAE1 expression in collecting ducts of end-stage kidneys from a family with SLC4A1 G609R-associated distal renal tubular acidosis. Clin Kidney J. 2017 Feb; 10 (1):135-140 Epub 2016 Aug 31
    View PubMed
  42. Marsenic O, Anderson M, Couloures KG, Hong WS, Kevin Hall E, Dahl N. Effect of the decrease in dialysate sodium in pediatric patients on chronic hemodialysis. Hemodial Int. 2016 Apr; 20 (2):277-85 Epub 2015 Dec 14
    View PubMed
  43. Ziganshin BA, Theodoropoulos P, Salloum MN, Zaza KJ, Tranquilli M, Mojibian HR, Dahl NK, Fang H, Rizzo JA, Elefteriades JA. Simple Renal Cysts as Markers of Thoracic Aortic Disease. J Am Heart Assoc. 2016 Jan 8; 5 (1) Epub 2016 Jan 08
    View PubMed
  44. Alam A, Dahl NK, Lipschutz JH, Rossetti S, Smith P, Sapir D, Weinstein J, McFarlane P, Bichet DG. Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy. Am J Kidney Dis. 2015 Oct; 66 (4):564-76 Epub 2015 May 07
    View PubMed
  45. Luciano RL, Dahl NK. Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management. Nephrol Dial Transplant. 2014 Feb; 29 (2):247-54 Epub 2013 Nov 08
    View PubMed
  46. Koraishy FM, Ngo TT, Israel GM, Dahl NK. CT urography for the diagnosis of medullary sponge kidney. Am J Nephrol. 2014; 39 (2):165-70 Epub 2014 Feb 11
    View PubMed
  47. Koraishy FM, Cohen RA, Israel GM, Dahl NK. Cystic kidney disease in a patient with systemic toxicity from long-term D-penicillamine use. Am J Kidney Dis. 2013 Oct; 62 (4):806-9 Epub 2013 June 21
    View PubMed
  48. Manjunath V, Moeckel G, Dahl NK. Acute kidney injury in a patient with sarcoidosis: hypercalciuria and hypercalcemia leading to calcium phosphate deposition. Clin Nephrol. 2013 Aug; 80 (2):151-5
    View PubMed
  49. Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS, TEMPO 3:4 Trial Investigators. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012 Dec 20; 367 (25):2407-18 Epub 2012 Nov 03
    View PubMed
  50. Parikh CR, Dahl NK, Chapman AB, Bost JE, Edelstein CL, Comer DM, Zeltner R, Tian X, Grantham JJ, Somlo S. Evaluation of urine biomarkers of kidney injury in polycystic kidney disease. Kidney Int. 2012 Apr; 81 (8):784-90 Epub 2012 Jan 18
    View PubMed
  51. Hall IE, Kashgarian M, Moeckel GW, Dahl NK. Resolution of proteinuria in a patient with focal segmental glomerulosclerosis following BiPAP initiation for obesity hypoventilation syndrome. Clin Nephrol. 2012 Jan; 77 (1):62-5
    View PubMed
  52. Singanamala S, Krishnamoorthy S, Perazella MA, Dahl NK. Recurrent flank pain from 'lobster claw'. NDT Plus. 2011 Aug; 4 (4):274-5 Epub 2011 Apr 27
    View PubMed
  53. Vigneault CB, Asch WS, Dahl NK, Bia MJ. Should living kidney donor candidates with impaired fasting glucose donate? Clin J Am Soc Nephrol. 2011 Aug; 6 (8):2054-9 Epub 2011 July 22
    View PubMed
  54. Mutter WP, Stillman IE, Dahl NK. Thrombotic microangiopathy and renal failure exacerbated by epsilon-aminocaproic acid. Am J Kidney Dis. 2009 Feb; 53 (2):346-50 Epub 2008 Sept 21
    View PubMed
  55. Dahl NK, Jiang L, Chernova MN, Stuart-Tilley AK, Shmukler BE, Alper SL. Deficient HCO3- transport in an AE1 mutant with normal Cl- transport can be rescued by carbonic anhydrase II presented on an adjacent AE1 protomer. J Biol Chem. 2003 Nov 7; 278 (45):44949-58 Epub 2003 Aug 21
    View PubMed
  56. Alper SL, Darman RB, Chernova MN, Dahl NK. The AE gene family of Cl/HCO3- exchangers. J Nephrol. 2002 Mar-Apr; 15 Suppl 5:S41-53
    View PubMed
  57. Dahl NK, Daunais MA, Liscum L. A second complementation class of cholesterol transport mutants with a variant Niemann-Pick type C phenotype. J Lipid Res. 1994 Oct; 35 (10):1839-49
    View PubMed
  58. Dahl NK, Gutheil WG, Liscum L. Abnormal regulation of low density lipoprotein-sensitive events in a cholesterol transport mutant. J Biol Chem. 1993 Aug 15; 268 (23):16979-86
    View PubMed
  59. Liscum L, Dahl NK. Intracellular cholesterol transport. J Lipid Res. 1992 Sep; 33 (9):1239-54
    View PubMed
  60. Dahl NK, Reed KL, Daunais MA, Faust JR, Liscum L. Isolation and characterization of Chinese hamster ovary cells defective in the intracellular metabolism of low density lipoprotein-derived cholesterol. J Biol Chem. 1992 Mar 5; 267 (7):4889-96
    View PubMed
  61. Pramanik P, Kanhouwa N, Kan LS. Hairpin and duplex formation in DNA fragments CCAATTTTGG, CCAATTTTTTGG, and CCATTTTTGG: a proton NMR study. Biochemistry. 1988 Apr 19; 27 (8):3024-31
    View PubMed
  62. Yuhasz , SC, Kanhouwa N, Shida T, Kan LS. DNA Synthesis: A Look at Sequence Dependent Conformational Anomalies BioTechniques. 1987; 5(1):54.